Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
3.640
-0.050 (-1.36%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Incannex Healthcare Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | - | 0.09 | 0.01 | - | - | 1.42 |
Other Revenue | - | - | - | - | 0.54 | 0 |
| - | 0.09 | 0.01 | - | 0.54 | 1.42 | |
Revenue Growth | - | 616.67% | - | - | -62.11% | 240.67% |
Cost of Revenue | - | - | - | - | 0 | 0.68 |
Gross Profit | - | 0.09 | 0.01 | - | 0.53 | 0.74 |
Selling, General & Admin | 17.94 | 13.13 | 17.17 | 8.01 | 3.55 | 4.39 |
Research & Development | 6.9 | 8.99 | 1.45 | 5.63 | 3.7 | 3.56 |
Other Operating Expenses | - | - | - | - | - | -0.03 |
Operating Expenses | 24.84 | 22.12 | 18.62 | 13.64 | 8.36 | 8.38 |
Operating Income | -24.84 | -22.03 | -18.61 | -13.64 | -7.82 | -7.64 |
Interest Expense | - | -0.3 | - | - | - | - |
Interest & Investment Income | 0.02 | 0.06 | 0.21 | 0.24 | 0 | 0 |
Currency Exchange Gain (Loss) | -0.01 | -0.29 | -0.03 | -0.07 | - | - |
Other Non Operating Income (Expenses) | -23.07 | -22.85 | - | - | -2.45 | -0.89 |
EBT Excluding Unusual Items | -47.94 | -45.41 | -18.43 | -13.46 | -10.27 | -8.53 |
Other Unusual Items | -0.48 | -1.47 | - | - | - | - |
Pretax Income | -48.41 | -46.89 | -18.43 | -48.81 | -10.27 | -8.53 |
Income Tax Expense | - | - | 0.03 | - | - | - |
Earnings From Continuing Operations | -48.41 | -46.89 | -18.46 | -48.81 | -10.27 | -8.53 |
Net Income | -48.41 | -46.89 | -18.46 | -48.81 | -10.27 | -8.53 |
Net Income to Common | -48.41 | -46.89 | -18.46 | -48.81 | -10.27 | -8.53 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 1 | 1 | 1 | 10 | 8 |
Shares Outstanding (Diluted) | 9 | 1 | 1 | 1 | 10 | 8 |
Shares Change | 1452.12% | 113.15% | 5.07% | -94.83% | 21.93% | 42.82% |
EPS (Basic) | -5.22 | -40.82 | -34.26 | -95.18 | -1.03 | -1.05 |
EPS (Diluted) | -5.22 | -40.82 | -34.26 | -95.18 | -1.03 | -1.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -17.73 | -12.52 | -16.12 | -11.07 | -8.82 | -5.18 |
Free Cash Flow Per Share | -1.91 | -10.90 | -29.92 | -21.58 | -0.89 | -0.64 |
Gross Margin | - | 100.00% | 100.00% | - | 99.19% | 51.94% |
Operating Margin | - | -25619.77% | -155058.33% | - | -1450.78% | -536.77% |
Profit Margin | - | -54517.44% | -153825.00% | - | -1904.94% | -599.33% |
Free Cash Flow Margin | - | -14559.30% | -134350.00% | - | -1636.97% | -364.13% |
EBITDA | -24.7 | -21.89 | -18.5 | -13.62 | - | - |
D&A For EBITDA | 0.15 | 0.14 | 0.1 | 0.02 | - | - |
EBIT | -24.84 | -22.03 | -18.61 | -13.64 | -7.82 | -7.64 |
Revenue as Reported | - | - | - | - | - | 1.48 |
Advertising Expenses | - | - | - | - | 1.89 | 3.26 |